# Three Arch Partners: portfolio, investments and team

> Three Arch Partners is a growth equity based in United States. 75 investments on record, latest Apr 2015. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/three-arch-partners (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Three Arch Partners

No cheque observed since Apr 2015, after 75 earlier cheques, and the website is dead.

Dormant Growth equity

Series B Series C Venture Biotechnology Dating

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 75 on record

Since the last cheque **4200** days **00** hrs **00** min **00** sec

Median round **$20M** Rounds led **0 of 75** Sole investor **2 rounds** Exits **24 from the portfolio** Mostly in **United States, 100%**

Pitch Three Arch Partners

## Three Arch Partners highlights

- 01 75 rounds on record
- 02 Mostly Series B and Series C: 50% of its rounds
- 03 Sole investor in 2 rounds, median $11M
- 04 24 exits from the portfolio

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Biotechnology Dating
- **Based in:** United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **75 appearances**

- **2015** 1 round
- **Apr** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series F · US **$34M** With 7 others
- **2013** 2 rounds
- **Nov** **[Ocera Therapeutics](https://millionrounds.com/company/ocera-therapeutics)** Venture · US · fiercebiotech.com **$28M** With 7 others
- **Mar** **[Nevro](https://millionrounds.com/company/nevro)** Series C · US · finsmes.com **$48M** With 8 others
- **2012** 3 rounds
- **Oct** **[Access Closure](https://millionrounds.com/company/access-closure)** Venture · US **$998K** With 2 others
- **Jan** **[iScience Interventional](https://millionrounds.com/company/iscience-interventional)** Venture · US · researchviews.com **$2.8M** With 5 others
- **Jan** **[Access Closure](https://millionrounds.com/company/access-closure)** Venture · US **$2.8M** With 1 other
- **2011** 5 rounds
- **Nov** **[Inova Labs](https://millionrounds.com/company/inova-labs)** Series B · US · sec.gov **$18M** With 2 others
- **Jul** **[Nevro](https://millionrounds.com/company/nevro)** Venture · US · finsmes.com **$58M** With 6 others
- **May** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series E · US · marketwire.com **$30M** With 7 others
- **Mar** **[Tibion Bionic Technologies](https://millionrounds.com/company/tibion-bionic-technologies)** Series B · US · earthtimes.org **$10M** With 1 other
- **Jan** **[VisionCare Ophthalmic Technologies](https://millionrounds.com/company/visioncare-ophthalmic-technologies)** Series E · US · finsmes.com **$31M** With 5 others
- **2010** 7 rounds
- **Oct** **[TriReme Medical](https://millionrounds.com/company/trireme-medical)** Series D · US · prnewswire.com **$17M** With 2 others
- **Jul** **[Ingenuity Systems](https://millionrounds.com/company/ingenuity-systems)** Venture · US · deals.venturebeat.com **$15M** With 3 others
- **Jun** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series C · US · calistogapharma.com **$40M** With 5 others
- **Jun** **[Baxano](https://millionrounds.com/company/baxano)** Series C · US · onbiovc.com **$30M** With 5 others
- **Jun** **[Voyage Medical](https://millionrounds.com/company/voyage-medical)** Series C · US · deals.venturebeat.com **$21M** With 2 others
- **Apr** **[Hemosphere](https://millionrounds.com/company/hemosphere)** Series A · US · onbiovc.com **$9.3M** With 6 others
- **Jan** **[Free & Clear](https://millionrounds.com/company/free-and-clear)** Venture · US · seattletimes.nwsource.com **$10M** With 2 others
- **2009** 6 rounds
- **Nov** **[Calibra Medical](https://millionrounds.com/company/calibra-medical)** Venture · US · deals.venturebeat.com **$1.4M** With 4 others
- **Oct** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series D · US · onbiovc.com **$30M** With 7 others
- **May** **[Visiogen](https://millionrounds.com/company/visiogen)** Series D · US · onbiovc.com **$40M** With 6 others
- **May** **[iScience Interventional](https://millionrounds.com/company/iscience-interventional)** Series F · US · onbiovc.com **$21M** With 7 others
- **May** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series B · US **$30M** With 3 others
- **Feb** **[SpinalMotion](https://millionrounds.com/company/spinalmotion)** Series C · US · venturebeat.com **$500K** With 3 others
- **2008** 13 rounds
- **Oct** **[Cardiac Concepts](https://millionrounds.com/company/cardiac-concepts)** Series B · US · equityhelpdesk.com **$21M** With 5 others
- **Sept** **[APT Pharmaceuticals](https://millionrounds.com/company/apt-pharmaceuticals)** Series A · US · aptbio.com **$32M** With 6 others
- **Sept** **[Baxano](https://millionrounds.com/company/baxano)** Series B · US **$20M** With 2 others
- **Aug** **[Voyage Medical](https://millionrounds.com/company/voyage-medical)** Series B · US · deals.venturebeat.com **$22M** With 2 others
- **Aug** **[Calibra Medical](https://millionrounds.com/company/calibra-medical)** Series B · US **$35M** With 4 others
- **May** **[NovaSys](https://millionrounds.com/company/novasys)** Venture · US · deals.venturebeat.com **$50M** With 10 others
- **Apr** **[Concert Pharmaceuticals](https://millionrounds.com/company/concert-pharmaceuticals)** Series C · US **$37M** With 11 others
- **Mar** **[Spiration](https://millionrounds.com/company/spiration)** Series G · US **$19M** With 5 others
- **Mar** **[Cameron Health](https://millionrounds.com/company/cameron-health)** Series E · US · deals.venturebeat.com **$14M** With 5 others
- **Jan** **[Arbor Surgical Technologies](https://millionrounds.com/company/arbor-surgical-technologies)** Series C · US **$20M** With 10 others
- **Jan** **[North American Scientific](https://millionrounds.com/company/north-american-scientific)** Venture **$16M** With 2 others
- **Jan** **[Benvenue Medical](https://millionrounds.com/company/benvenue-medical)** Series B · US · benvenuemedical.com **$15M** With 2 others
- **Jan** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series A · US **$5.2M** With 3 others
- **2007** 11 rounds
- **Oct** **[TriReme Medical](https://millionrounds.com/company/trireme-medical)** Series C · US · trirememedical.com **$16M** With 1 other
- **Jul** **[Satiety](https://millionrounds.com/company/satiety)** Series D · US · venturebeat.com **$30M** With 6 others
- **May** **[Arete Therapeutics](https://millionrounds.com/company/arete-therapeutics)** Series A · US **$35M** With 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **24 in all**

**[LipoScience](https://millionrounds.com/company/liposcience)** Bought by [LabCorp](https://millionrounds.com/fund/labcorp) **$63M** Sept 2014

**[Access Closure](https://millionrounds.com/company/access-closure)** Bought by [Cardinal Health](https://millionrounds.com/fund/cardinal-health) **$320M** Apr 2014

**[SquareOne](https://millionrounds.com/company/squareone)** Bought by Omnia Media **Undisclosed** Jan 2014

**[Tibion Bionic Technologies](https://millionrounds.com/company/tibion-bionic-technologies)** Bought by AlterG **Undisclosed** Jun 2013

**[Ingenuity Systems](https://millionrounds.com/company/ingenuity-systems)** Bought by [Qiagen](https://millionrounds.com/fund/qiagen) **Undisclosed** Apr 2013

**[Baxano](https://millionrounds.com/company/baxano)** Bought by TranS1 **Undisclosed** Mar 2013

**[Epocrates](https://millionrounds.com/company/epocrates)** Bought by Athenahealth **Undisclosed** Jan 2013

**[Calibra Medical](https://millionrounds.com/company/calibra-medical)** Bought by [Johnson & Johnson](https://millionrounds.com/fund/johnson-and-johnson) **Undisclosed** Jul 2012

**[Ascend Health](https://millionrounds.com/company/ascend-health)** Bought by [Universal Health Services](https://millionrounds.com/fund/universal-health-services) **Undisclosed** Jun 2012

**[Cameron Health](https://millionrounds.com/company/cameron-health)** Bought by [Boston Scientific](https://millionrounds.com/fund/boston-scientific) **Undisclosed** Jun 2012

**[Hemosphere](https://millionrounds.com/company/hemosphere)** Bought by CryoLife **$22M** May 2012

**[VetCentric](https://millionrounds.com/company/vetcentric)** Bought by Vets First Choice **Undisclosed** Jan 2012

**[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Bought by [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) **$375M** Feb 2011

**[Epocrates](https://millionrounds.com/company/epocrates)** Listed **Undisclosed** Feb 2011

**[Concuity](https://millionrounds.com/company/concuity)** Bought by The Advisory Board Company **Undisclosed** Mar 2010

**[Evalve](https://millionrounds.com/company/evalve)** Bought by [Abbott Labs](https://millionrounds.com/fund/abbott-labs) **$410M** Sept 2009

**[Visiogen](https://millionrounds.com/company/visiogen)** Bought by [Abbott Labs](https://millionrounds.com/fund/abbott-labs) **$400M** Sept 2009

**[Pegasus Biologics](https://millionrounds.com/company/pegasus-biologics)** Bought by Synovis Life Technologies **$12M** Jul 2009

**[Reliant Technologies](https://millionrounds.com/company/reliant-technologies)** Bought by Thermage **$66M** Jan 2009

**[LipoSonix](https://millionrounds.com/company/liposonix)** Bought by [Medicis Pharmaceutical](https://millionrounds.com/fund/medicis-pharmaceutical) **$300M** Jun 2008

The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series B Series C Venture

Median round joined **$20M** the round, not its cheque Alone, median **$11M**

Led 0 of 75 rounds **0%**

- **Sole investor:** 2 rounds
- **Last cheque:** Apr 2015
- **Exits:** 24 from the portfolio

Rounds by stage said on their site

- Series B *18*
- Series C *18*
- Venture *14*
- Series A *8*
- Series E *7*
- Series D *7*

Cheques by year Led Joined

2000 2015

Often in the room with

- [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 10
- [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) 9
- [ONSET Ventures](https://millionrounds.com/fund/onset-ventures) 9
- [Skyline Ventures](https://millionrounds.com/fund/skyline-ventures) 9
- [Affinity Capital Management](https://millionrounds.com/fund/affinity-capital-management) 8
- [InterWest Partners](https://millionrounds.com/fund/interwest-partners) 8

**Pitching Three Arch Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Three Arch Partners. A count of rooms they were both in, not a relationship either has claimed.

[**Versant Ventures** VC firm **10** rounds together](https://millionrounds.com/fund/versant-ventures)[**New Leaf Venture Partners** VC firm **9** rounds together](https://millionrounds.com/fund/new-leaf-venture-partners)[**ONSET Ventures** VC firm **9** rounds together](https://millionrounds.com/fund/onset-ventures)[**Skyline Ventures** VC firm **9** rounds together](https://millionrounds.com/fund/skyline-ventures)[**Affinity Capital Management** VC firm **8** rounds together](https://millionrounds.com/fund/affinity-capital-management)[**InterWest Partners** VC firm **8** rounds together](https://millionrounds.com/fund/interwest-partners)[**Delphi Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/delphi-ventures)[**Frazier Healthcare Partners** Private equity **7** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)[**Polaris Partners** VC firm **7** rounds together](https://millionrounds.com/fund/polaris-partners)[**Alta Partners** VC firm **6** rounds together](https://millionrounds.com/fund/alta-partners)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **6** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**Sprout Group** Growth equity **6** rounds together](https://millionrounds.com/fund/sprout-group)

## Quick answers about Three Arch Partners

### What does Three Arch Partners invest in?

Three Arch Partners invests most often at Series B and Series C (50% of the rounds on record), in sectors such as Biotechnology and Dating.

### How active is Three Arch Partners?

75 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2015.

### How big are Three Arch Partners's cheques?

The median round it joins is $20M.

### Does Three Arch Partners lead rounds?

Rarely, if at all: none of its 75 investments on record names it as the lead.

### Where does Three Arch Partners invest?

Most of the companies it backs are in the United States (100%).

### Is Three Arch Partners investing now?

It looks quiet: no investment on record since Apr 2015.

### Who does Three Arch Partners invest alongside?

Most often Versant Ventures (10 rounds together), New Leaf Venture Partners (9 rounds together) and ONSET Ventures (9 rounds together).

### What kind of investor is Three Arch Partners?

Three Arch Partners is a growth equity firm based in United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=three-arch-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=three-arch-partners)